BR112021000201A2 - composição farmacêutica contendo um peptídeo - Google Patents
composição farmacêutica contendo um peptídeo Download PDFInfo
- Publication number
- BR112021000201A2 BR112021000201A2 BR112021000201-4A BR112021000201A BR112021000201A2 BR 112021000201 A2 BR112021000201 A2 BR 112021000201A2 BR 112021000201 A BR112021000201 A BR 112021000201A BR 112021000201 A2 BR112021000201 A2 BR 112021000201A2
- Authority
- BR
- Brazil
- Prior art keywords
- cys
- tyr
- vehicle
- asn
- glu
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201811025533 | 2018-07-09 | ||
IN201811025533 | 2018-07-09 | ||
PCT/IB2019/000716 WO2020012243A2 (en) | 2018-07-09 | 2019-07-08 | Pharmaceutical composition containing a peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021000201A2 true BR112021000201A2 (pt) | 2021-08-10 |
Family
ID=68165587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021000201-4A BR112021000201A2 (pt) | 2018-07-09 | 2019-07-08 | composição farmacêutica contendo um peptídeo |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR115724A1 (es) |
BR (1) | BR112021000201A2 (es) |
CL (1) | CL2021000022A1 (es) |
CO (1) | CO2021000158A2 (es) |
MX (1) | MX2021000312A (es) |
WO (1) | WO2020012243A2 (es) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007033427A1 (en) | 2005-09-23 | 2007-03-29 | Metabolic Pharmaceuticals Limited | Stabilisation of peptides with basic amino acids |
MX2020005326A (es) | 2008-08-15 | 2022-03-03 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
EP2238979A1 (en) * | 2009-04-06 | 2010-10-13 | LEK Pharmaceuticals d.d. | Active pharmaceutical ingredient adsorbed on solid support |
US9616097B2 (en) * | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
JP2016521249A (ja) | 2012-07-12 | 2016-07-21 | フォレスト ラボラトリーズ ホールディングス リミテッド | リナクロチド組成物 |
WO2016024291A1 (en) | 2014-08-11 | 2016-02-18 | Sun Pharmaceutical Industries Ltd. | Linaclotide stable composition |
EP3233059A1 (en) * | 2014-12-19 | 2017-10-25 | Synthon B.V. | Pharmaceutical composition comprising amorphous lenalidomide |
-
2019
- 2019-07-08 WO PCT/IB2019/000716 patent/WO2020012243A2/en active Application Filing
- 2019-07-08 BR BR112021000201-4A patent/BR112021000201A2/pt unknown
- 2019-07-08 MX MX2021000312A patent/MX2021000312A/es unknown
- 2019-07-10 AR ARP190101936A patent/AR115724A1/es unknown
-
2021
- 2021-01-06 CL CL2021000022A patent/CL2021000022A1/es unknown
- 2021-01-12 CO CONC2021/0000158A patent/CO2021000158A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR115724A1 (es) | 2021-02-17 |
CL2021000022A1 (es) | 2021-07-19 |
WO2020012243A3 (en) | 2020-03-05 |
MX2021000312A (es) | 2021-06-08 |
CO2021000158A2 (es) | 2021-01-18 |
WO2020012243A2 (en) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210290554A1 (en) | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration | |
PT2079445E (pt) | Composições de enzimas digestivas estáveis | |
JP2009531275A5 (es) | ||
US20150132375A1 (en) | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration | |
BRPI0707616A2 (pt) | formulaÇÕes para um efetor de junÇço oclusiva | |
BR112012021275B1 (pt) | Formulação compreendendo um adsorvente misturado com carragenina, para entrega oral e liberação controlada de adsorventes no intestino, e, uso de uma formulação | |
US20100068290A1 (en) | Coated pellets | |
US20230113303A1 (en) | Granular Pharmaceutical Composition | |
CN107693515B (zh) | 含碱化剂和艾曲泊帕的药物组合物及其用途 | |
BR112021000201A2 (pt) | composição farmacêutica contendo um peptídeo | |
JP2004051502A (ja) | 成長ホルモン含有安定化粉末製剤 | |
KR100289141B1 (ko) | 펩타이드의 경구 투여를 위한 안정화된 조성물 | |
TWI531374B (zh) | 適於口服之gc-c受體激動劑多肽之穩定固態調配物 | |
JPH02207A (ja) | 塩酸ブロムヘキシン含有製剤 | |
TW201440782A (zh) | 米卡芬淨或其鹽的醫藥組成物 | |
EA040381B1 (ru) | Стабильная твердая композиция полипептидного агониста gc-c рецептора, приемлемая для перорального введения |